- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03278093
Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy
January 18, 2019 updated by: St George's, University of London
The Feasibility and Effect of Ankle Foot Orthoses and Underfoot Vibration on the Postural Stability of People With Inherited Neuropathy
A cross-sectional study which will look at the effects of AFO's and vibrating insoles on balance performance in people with CMT disease.
Study Overview
Status
Unknown
Detailed Description
Balance impairments and falls are more common in people who have Charcot Marie Tooth disease (CMT) than in people without the condition.
CMT is a condition which affects the nerves causing a variety of symptoms including sensation impairments and weakness.
The impairments are usually most evident in the feet and hands, but they can progress very slowly moving closer to the trunk.
Ankle Foot Orthoses (AFO's) are often prescribed to help with walking and daily function.
So far the effects of AFO's on standing balance in people who have CMT have not been looked at.
Insoles are also often prescribed to realign foot deformity and reduce pain.
Insoles which give a vibratory input have had a positive impact on walking in older people but have not been looked at in balance and in CMT.
Insoles which give a vibration feedback to the sole of the foot when worn have been designed.
This study will look at whether the use of AFO's and the vibratory insoles have an effect on standing balance in people with CMT or related peripheral neuropathy.
Balance measurements will be taken in a single session comparing a variety of postures.
Patients will be recruited from neurology outpatient clinics at the National Hospital of Neurology and Neurosurgery.
Study Type
Observational
Enrollment (Anticipated)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Magdalena Dudziec
- Phone Number: 020 3108 7520
- Email: m.dudziec@ucl.ac.uk
Study Contact Backup
- Name: Gita Ramdharry
- Phone Number: 020 3108 7517
- Email: g.ramdharry@ucl.ac.uk
Study Locations
-
-
-
London, United Kingdom, WC1N 3BG
- Recruiting
- National Hopsital of Neurology and Neurosurgery
-
Contact:
- Magdalena Dudziec
- Phone Number: 020 3108 7520
- Email: m.dudziec@ucl.ac.uk
-
Contact:
- Gita Ramdharry
- Phone Number: 020 3108 7517
- Email: g.ramdharry@ucl.ac.uk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Mobile adults who have CMT with both motor and sensory symptoms.
Description
Inclusion Criteria:
- Clinical or genetically confirmed diagnosis of CMT or related peripheral neuropathy
- Mixed sensory and motor presentation
- Over 18 years
- Able to stand unsupported for five minutes
- Able to walk for 50m with or without a walking stick or orthotic devices
Exclusion Criteria:
- Presence of other significant neurological disorders (such as multiple sclerosis, cerebrovascular diseases, epilepsy, movement disorders), or major comorbidities (e.g. vestibular dysfunction, use of medication which may affect balance, cognitive impairment, presence of medical conditions in which exercise training may be detrimental).
- Presence of peripheral neuropathy caused by a condition other than CMT.
- Limb surgery during the six months prior to screening (or planned before final assessment).
- Women of child-bearing age if they are pregnant, planning a pregnancy during their time in the study or in the 12 weeks following giving birth. This is due to the effects of pregnancy on balance.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Posturography
Time Frame: 30 second caputer in a variety of conditions
|
CODA motion movement analysis for postural sway Measures will be taken in all conditions with feet together and feet apart.
Both conditions will also be looked at with eyes open and eyes closed.
|
30 second caputer in a variety of conditions
|
force measures
Time Frame: 30 second caputer in a variety of conditions
|
AMTI forceplate for centre of pressure .
Measures will be taken in all conditions with feet together and feet apart.
Both conditions will also be looked at with eyes open and eyes closed.
|
30 second caputer in a variety of conditions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gita Ramdharry, Senior Physiotherapist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2017
Primary Completion (Anticipated)
February 20, 2019
Study Completion (Anticipated)
February 20, 2019
Study Registration Dates
First Submitted
September 8, 2017
First Submitted That Met QC Criteria
September 8, 2017
First Posted (Actual)
September 11, 2017
Study Record Updates
Last Update Posted (Actual)
January 22, 2019
Last Update Submitted That Met QC Criteria
January 18, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Neuromuscular Diseases
- Stomatognathic Diseases
- Neurodegenerative Diseases
- Heredodegenerative Disorders, Nervous System
- Nervous System Malformations
- Polyneuropathies
- Peripheral Nervous System Diseases
- Tooth Diseases
- Nerve Compression Syndromes
- Charcot-Marie-Tooth Disease
- Hereditary Sensory and Motor Neuropathy
Other Study ID Numbers
- 16.0029
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Neuropathy
-
Arash Asher, MDVoxxLifeRecruitingNeuropathy | Chemotherapy-induced Peripheral Neuropathy | Neuropathy;PeripheralUnited States
-
Beth Israel Deaconess Medical CenterPhoenix Neurological Associates, LTDCompletedSmall Fiber Neuropathy | Idiopathic Peripheral NeuropathyUnited States
-
M.D. Anderson Cancer CenterFoundation for Anesthesia Education and ResearchRecruitingNeuropathy;PeripheralUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Yale University; University of Manchester; Maastricht University; Ospedale San... and other collaboratorsUnknownPainful Peripheral Neuropathy | Painless Peripheral Neuropathy
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownDiabetic Peripheral Neuropathy
-
Hawler Medical UniversityUnknownDiabetic Peripheral NeuropathyIraq
-
Baylor College of MedicineNeuroMetrix, Inc.RecruitingPain | Neuropathy | Chemotherapy-induced Peripheral NeuropathyUnited States
-
Institut Cancerologie de l'OuestGrünenthal GmbHNot yet recruitingChemotherapy-induced Peripheral Neuropathy
-
Odense University HospitalAarhus University Hospital; University of Southern Denmark; Sygehus LillebaeltRecruitingChemotherapy-induced Peripheral NeuropathyDenmark